Drug of Choice for Pediatric UTI
For an otherwise healthy child with uncomplicated urinary tract infection, amoxicillin-clavulanate, trimethoprim-sulfamethoxazole (if local E. coli resistance is <10%), or a cephalosporin (such as cefixime or cephalexin) are the recommended first-line oral antibiotics for 7-14 days. 1, 2
Initial Antibiotic Selection Algorithm
First-line oral options include:
Amoxicillin-clavulanate at 40-45 mg/kg/day divided every 12 hours is a preferred first-choice agent because the clavulanate component overcomes β-lactamase production, maintaining 75-82% susceptibility against pediatric E. coli isolates despite high amoxicillin-alone resistance (median 75% globally). 1, 2
Cephalosporins such as cefixime (8 mg/kg once daily) or cephalexin (50-100 mg/kg/day divided into 4 doses) provide excellent E. coli coverage and are FDA-approved for uncomplicated UTI in children ≥6 months. 1, 3
Trimethoprim-sulfamethoxazole may be used only when local E. coli resistance rates are documented to be <10% for pyelonephritis or <20% for lower UTI, as resistance patterns vary significantly by region. 4, 1, 2
Avoid amoxicillin monotherapy: The WHO removed amoxicillin from empiric recommendations in 2021 after global surveillance showed 75% (range 45-100%) of E. coli urinary isolates were resistant, making it unreliable for empiric treatment. 4, 1
Treatment Duration by Clinical Presentation
For febrile UTI/pyelonephritis:
- Treat for 7-14 days total (10 days is most commonly recommended), as courses shorter than 7 days are inferior and increase risk of treatment failure. 1, 2
For uncomplicated cystitis (non-febrile lower UTI):
- Shorter courses of 3-5 days appear comparable to 7-14 days in children >2 years, though 7-10 days remains standard practice for moderate-to-severe symptoms. 1, 2
When to Use Parenteral Therapy
Reserve IV/IM antibiotics for:
- Children who appear clinically toxic or septic 1, 2
- Inability to retain oral intake or vomiting 1, 2
- Age <3 months (neonates <28 days require hospitalization with ampicillin + aminoglycoside or third-generation cephalosporin for 14 days total) 4, 1
- Uncertain compliance with oral medications 1, 2
Parenteral option: Ceftriaxone 50-75 mg/kg IV/IM every 24 hours, then transition to oral therapy to complete 7-14 day course once clinically improved. 1, 2
Critical Pitfalls to Avoid
Never use nitrofurantoin for febrile UTI or pyelonephritis in infants/children, as it does not achieve adequate serum or renal parenchymal concentrations to treat upper tract infection—reserve it only for uncomplicated cystitis. 1, 2
Do not treat for <7 days for febrile UTI, as single-dose or 3-day regimens are inferior and associated with higher recurrence rates (23% vs 2% in one study). 1, 5
Obtain urine culture before starting antibiotics via catheterization (not bag collection, which has 85% false-positive rate) to guide antibiotic adjustment and confirm diagnosis. 1
Avoid fluoroquinolones in children due to musculoskeletal safety concerns affecting tendons, joints, and nervous system—reserve only for severe infections where benefits outweigh risks. 1, 2
Do not fail to consider local resistance patterns: If your region has >10% E. coli resistance to trimethoprim-sulfamethoxazole, choose amoxicillin-clavulanate or a cephalosporin instead. 4, 1
Follow-Up and Imaging
Clinical reassessment within 24-48 hours is critical to confirm fever resolution and treatment response; if fever persists >48 hours on appropriate therapy, evaluate for antibiotic resistance or anatomic abnormality. 1
Renal and bladder ultrasound (RBUS) is recommended for all children <2 years with first febrile UTI to detect anatomic abnormalities, but is not routinely required for children >2 years with uncomplicated first UTI. 1, 2
Voiding cystourethrography (VCUG) is not recommended routinely after first UTI, but should be performed after a second febrile UTI or if RBUS shows hydronephrosis, scarring, or findings suggesting high-grade vesicoureteral reflux. 1, 2
Age-Specific Considerations
Neonates (<28 days):
- Require hospitalization with parenteral ampicillin + gentamicin or third-generation cephalosporin for 14 days total due to higher risk of bacteremia and serious complications. 4, 1
Infants 1-24 months:
- Can use oral cefixime, cephalexin, or amoxicillin-clavulanate if well-appearing and stable, with ceftriaxone reserved for toxic appearance or inability to tolerate oral intake. 1
Children >2 years: